Hachisuka K, Okazaki T, Ogata H
Department of Rehabilitation Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
J UOEH. 1997 Jun 1;19(2):107-21. doi: 10.7888/juoeh.19.107.
To confirm concurrent validity of the final revision of the self-rating Barthel index (SB) and its test-retest reliability, we investigated 171 stroke outpatients without severe aphasia or dementia who were seen by a doctor on predetermined days at eight different hospitals. For 41 patients, the differences in scores among the original Barthel index (BI) and Granger's BI and SB were examined by the Friedman two-way analysis of variance and Wilcoxon matched-pairs signed-ranks test, and the difference in scores between Functional Independence Measure motor score (FIM-MS) and three-level scale FIM-MS was determined by the Wilcoxon's matched-pairs signed-ranks test. Concurrent validity of the SB was confirmed by Spearman's correlation coefficients with the original BI and FIM-MS, and internal consistency of the five measuring instruments was examined. For all 171 patients test-retest reliability of the SB was examined with the Spearman's correlation coefficient for total scores and kappa coefficients for each ADL item. Regression analysis was performed to determine what factors were related with test-retest reliability. Total scores of the SB and Granger's BI and the three-level scale FIM-MS were significantly higher than those of the original BI and FIM-MS, respectively. Correlation coefficients of the SB with the original BI and FIM-MS were 0.994 and 0.904, respectively, and its alpha-coefficient was 0.842. Test-retest reliability of the total score was 0.835 by the correlation coefficient, and kappa coefficients of 1 and 12 ADL items were fair and good, respectively. Regression analysis revealed that self-rating by a patient with a high SB total score is more accurate. Therefore, the SB has good concurrent validity and is well-related with the original BI and FIM, and its test-retest reliability is sufficiently high for practical use.
为了验证自评巴氏指数(SB)最终修订版的同时效度及其重测信度,我们调查了171例无严重失语或痴呆的中风门诊患者,这些患者于预定日期在八家不同医院接受医生检查。对于41例患者,通过Friedman双向方差分析和Wilcoxon配对符号秩检验检查了原始巴氏指数(BI)、格兰杰BI和SB之间的得分差异,并通过Wilcoxon配对符号秩检验确定了功能独立性测量运动评分(FIM-MS)和三级量表FIM-MS之间的得分差异。通过Spearman相关系数与原始BI和FIM-MS确认了SB的同时效度,并检查了五种测量工具的内部一致性。对于所有171例患者,用总得分的Spearman相关系数和每个ADL项目的kappa系数检查了SB的重测信度。进行回归分析以确定哪些因素与重测信度相关。SB、格兰杰BI和三级量表FIM-MS的总得分分别显著高于原始BI和FIM-MS。SB与原始BI和FIM-MS的相关系数分别为0.994和0.904,其α系数为0.842。总得分的重测信度通过相关系数为0.835,1个和12个ADL项目的kappa系数分别为中等和良好。回归分析表明,SB总分高的患者自评更准确。因此,SB具有良好的同时效度,与原始BI和FIM相关性良好,其重测信度足够高,可实际应用。